Tag Archives: T-ALL

10Oct/22

New Breakthrough in Anti-Cancer! PROTAC has Obtained Preclinical Proof of Concept for T-ALL Treatment

October 10, 2022PROTAC News, PROTAC ResearchCancer, E3 ligase, protac, T-ALLbiolabs

Acute lymphoblastic leukemia (ALL) is a common disease. B-ALL and T-ALL account for 85% and 15% of the two lymphatic lineages of ALL, respectively, but patients with T-ALL have poor life qualityRead More…

13Oct/20

Basic Research Progress of PROTAC in Hematological Diseases-Part one

October 13, 2020PROTAC News, PROTAC ResearchHematological Diseases, protac, T-ALL, T-cell Acute Lymphoblastic Leukaemia, T-cell Lymphomabiolabs

Proteolysis targeted chimera (PROTAC) is a rapidly developed technology in recent years, which provides the possibility for many undruggable targets, and has become the focus of protein drug researchers. Hematologic malignancies areRead More…

PROTAC Research
PROTAC News